Post-kala-azar dermal leishmaniasis in visceral leishmaniasis-endemic communities in Bihar, India

Tropical Medicine and International Health

Volumn 17, Issue 11, 2012, Pages 1345-1348

  Singh, Rudra Pratap ^a   Picado, Albert ^b,c   Alam, Shahnawaz ^a   Hasker, Epco ^b   Singh, Shri Prakash ^a   Ostyn, Bart ^b   Chappuis, François ^d   Sundar, Shyam ^a   Boelaert, Marleen ^b  

^a BANARAS HINDU UNIVERSITY   (India)

^b INSTITUTE OF TROPICAL MEDICINE   (Belgium)

^c CENTRE FOR RESEARCH IN ENVIRONMENTAL EPIDEMIOLOGY CREAL   (Spain)

^d GENEVA UNIVERSITY HOSPITALS   (Switzerland)

Author keywords

Bihar; Kala azar; Leishmania donovani; PKDL; Post kala azar dermal leishmaniasis; Visceral leishmaniasis

Indexed keywords

AMPHOTERICIN B; MILTEFOSINE; PAROMOMYCIN; STIBOGLUCONATE SODIUM;

DISEASE; DISEASE PREVALENCE; DISEASE TREATMENT; ENDEMIC SPECIES; ENDEMISM; SKIN DISORDER;

ADOLESCENT; ADULT; ARTICLE; CHILD; CLINICAL ARTICLE; CLINICAL FEATURE; COMMUNITY; DISEASE ASSOCIATION; ENDEMIC DISEASE; FEMALE; HUMAN; INDIA; MALE; MEDICAL HISTORY; POST KALA AZAR DERMAL LEISHMANIASIS; PREVALENCE; SCHOOL CHILD; SKIN DEFECT; SKIN LEISHMANIASIS; SKIN MANIFESTATION; VISCERAL LEISHMANIASIS;

BIHAR; KALA AZAR; KALA-AZAR; LCPK; LEISHMANIA DONOVANI; LEISHMANIASIS CUTÁNEA POST-KALA-AZAR; LEISHMANIASIS VISCERAL; LEISHMANIOSE CUTANÉE POST KALA-AZAR; LEISHMANIOSE VISCÉRALE; PKDL; PKLD; POST-KALA-AZAR DERMAL LEISHMANIASIS; VISCERAL LEISHMANIASIS;

ADOLESCENT; ADULT; ANTIPROTOZOAL AGENTS; CHILD; ENDEMIC DISEASES; FEMALE; HUMANS; INDIA; LEISHMANIA DONOVANI; LEISHMANIASIS, CUTANEOUS; LEISHMANIASIS, VISCERAL; MALE; PREVALENCE; SEVERITY OF ILLNESS INDEX;

BIHAR; INDIA;

LEISHMANIA DONOVANI; NASO HEXACANTHUS;

EID: 84867913843     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/j.1365-3156.2012.03067.x     Document Type: Article

References (14)

1. Boelaert M, Meheus F, Sanchez A et al. (2009) The poorest of the poor: a poverty appraisal of households affected by visceral leishmaniasis in Bihar, India. Tropical Medicine and International Health, 14, 639-644.
2. Das VN, Pandey K, Verma N et al. (2009) Short report: development of post-kala-azar dermal leishmaniasis (PKDL) in miltefosine-treated visceral leishmaniasis. American Journal of Tropical Medicine and Hygiene, 80, 336-338.
3. Kumar D, Ramesh V, Verma S, Ramam M & Salotra P (2009) Post-kala-azar dermal leishmaniasis (PKDL) developing after treatment of visceral leishmaniasis with amphotericin B and miltefosine. Annals of Tropical Medicine and Parasitology, 103, 727-730.
4. Mondal D, Nasrin KN, Huda MM et al. (2010) Enhanced case detection and improved diagnosis of PKDL in a Kala-azar-endemic area of Bangladesh. PLoS Neglected Tropical Diseases, 4, e832.
5. Pandey K, Das VN, Singh D et al. (2012) Post-kala-azar dermal leishmaniasis in a patient treated with injectable paromomycin for visceral leishmaniasis in India. Journal of Clinical Microbiology, 50, 1478-1479.
6. Picado A, Singh SP, Rijal S et al. (2010) Longlasting insecticidal nets for prevention of Leishmania donovani infection in India and Nepal: paired cluster randomised trial. BMJ, 341, c6760.
7. Rahman KM, Islam S, Rahman MW et al. (2010) Increasing incidence of post-kala-azar dermal leishmaniasis in a population-based study in Bangladesh. Clinical Infectious Diseases, 50, 73-76.
8. Rai RN, Kumar M, Srivastava A et al. (1989) Clinico-epidemiological profiles of post-kala-azar dermal leishmaniasis in Varanasi. Journal of Communicable Diseases, 21, 214-217.
9. Singh S, Kumar J, Singh R & Dwivedi SN (2000) Hepatitis B and C viral infections in Indian kala-azar patients receiving injectable anti-leishmanial drugs: a community-based study. International Journal of Infectious Diseases, 4, 203-208.
10. Stauch A, Sarkar RR, Picado A et al. (2011) Visceral leishmaniasis in the Indian subcontinent: modelling epidemiology and control. PLoS Neglected Tropical Diseases, 5, e1405.
11. Thakur CP, Kumar A, Mitra G et al. (2008) Impact of amphotericin-B in the treatment of kala-azar on the incidence of PKDL in Bihar, India. Indian Journal of Medical Research, 128, 38-44.
12. Uranw S, Ostyn B, Rijal A et al. (2011) Post-kala-azar dermal leishmaniasis in Nepal: a retrospective cohort study (2000-2010). PLoS Neglected Tropical Diseases, 5, e1433.
13. WHO (2010) Control of the leishmaniasis: report of a meeting of the WHO Expert Committee on the Control of Leishmaniases, Geneva, 22-26 March 2010. WHO Technical Report Series. World Health Organization, Geneva.
14. Zijlstra EE, Musa AM, Khalil EA, El-Hassan IM & El-Hassan AM (2003) Post-kala-azar dermal leishmaniasis. Lancet Infectious Diseases, 3, 87-98.